Insider Shareholders with Direct Ownership of Altimmune, Inc. (ALT)
This section provides a comprehensive overview of the insiders with direct ownership of Altimmune, Inc. (ALT). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Altimmune, Inc. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Vipin K Garg
President and CEO |
236,501 | 205,193 | 355,082 $1.89 Million | 55 |
Feb 02, 2025
Reduced 2.28%
|
M Scot Roberts
Chief Scientific Officer |
168,475 | 104,649 | 73,220 $389,530 | 37 |
Feb 02, 2025
Reduced 3.07%
|
Richard I Eisenstadt
Chief Financial Officer |
53,259 | 8,247 | 45,012 $239,463 | 11 |
Jan 31, 2024
Added 9.31%
|
Raymond M Jordt
Chief Business Officer |
43,743 | 8,850 | 34,902 $185,678 | 10 |
Jan 31, 2025
Added 6.97%
|
Mitchel Sayare
Director |
25,275 | 0 | 26,363 $140,251 | 1 |
Sep 24, 2020
Added 48.95%
|
David Drutz
Director |
19,528 | 0 | 20,151 $107,203 | 8 |
Nov 18, 2022
Added 0.69%
|
William Michael Brown
Chief Financial Officer |
1,740 | 0 | 17,721 $94,275 | 2 |
Jul 31, 2021
Added 4.33%
|
Matthew Scott Harris
Chief Medical Officer |
134,343 | 128,358 | 14,069 $74,847 | 34 |
Mar 07, 2025
Reduced 82.81%
|
Andrew Shutterly
Acting Chief Financial Officer |
1,259 | 0 | 11,372 $60,499 | 1 |
Jul 31, 2024
Added 9.97%
|
Gregory L Weaver
Chief Financial Officer |
10,000 | 0 | 10,000 $53,200 | 1 |
Mar 13, 2025
Added 50.0%
|
Klaus Schafer
Director |
19,129 | 10,150 | 9,179 $48,832 | 4 |
Jun 20, 2022
Added 0.65%
|
Philip Hodges
Director |
16,850 | 8,500 | 8,731 $46,448 | 3 |
Mar 01, 2021
Reduced 40.73%
|
Wayne Pisano
Director |
36,850 | 30,352 | 8,498 $45,209 | 4 |
Dec 22, 2022
Reduced 70.18%
|
John Gill
Director |
16,850 | 11,139 | 2,771 $14,741 | 3 |
Aug 12, 2022
Reduced 49.48%
|
Catherine A. Sohn
Director |
1,000 | 0 | 1,000 $5,320 | 1 |
Mar 17, 2025
Added 50.0%
|
Diane Jorkasky
Director |
17,610 | 17,610 | 0 $0 | 2 |
Jun 27, 2022
Reduced 100.0%
|